Japan
· Delayed Price · Currency is JPY Nipro Company Description
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses.
Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ products, functional products, dialysis products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products.
This business also operates dialysis and training centers. The company’s Pharmaceutical-Related business engages in the contract manufacturing of pharmaceutical products with containers for combination products, including injectable kit products consigned by other pharmaceutical companies.
The business also provides injectable and oral drugs products. Its PharmaPackaging business offers pharmaceutical packaging containers and glass tubing, such as molded components for vials, syringes, rubber stoppers, and devices used to administer pharmaceuticals; and glass for thermos bottles, lighting and containers for combination products, as well glass for ampoules.
It serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Settsu, Japan.
| Country | Japan |
| Founded | 1947 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 38,117 |
| CEO | Yoshihiko Sano |
Contact Details
Address: 3-26, Senriokashinmachi Settsu, 566-8510 Japan | |
| Phone | 81 6 6372 2331 |
| Website | nipro.co.jp |
Stock Details
| Ticker Symbol | 8086 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3673600007 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Yoshihiko Sano | Chief Executive Officer |